Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Pollard

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Epilepsy Currents|September 18, 2020
The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society MembershipDara V F Albert, Rohit R Das, Jayant N Acharya, et al.
Epilepsia|March 2, 2013
Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trialsDale C Hesdorffer, Jacqueline A French, Kelly Posner, et al.
Epilepsia|July 4, 2019
Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participantsJacqueline A French, Robert Wechsler, Michael A Gelfand, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 13, 2014
Structure of human Bloom's syndrome helicase in complex with ADP and duplex DNAMichael K Swan, Valerie Legris, Adam Tanner, et al.
Frontiers in Neurology|January 8, 2013
The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant EpilepsyJohn R Pollard, Ofer Eidelman, Gregory P Mueller, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 30, 2015
Lateral Transorbital Endoscopic Access to the Hippocampus, Amygdala, and Entorhinal Cortex: Initial Clinical ExperienceH Isaac Chen, Leif-Erik Bohman, Lyndsey Emery, et al.
Cancer Research|October 2, 2014
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responsesRozenn Jossé, Scott E Martin, Rajarshi Guha, et al.
The Lancet. Neurology|February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trialMichael D Privitera, Timothy E Welty, Barry E Gidal, et al.
Oncotarget|October 22, 2015
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibitionFiona K Middleton, Miranda J Patterson, Claire J Elstob, et al.
American Journal of Medical Genetics. Part A|February 6, 2024
Expanding the phenotype of UPF3B-related disorder: Case reports and literature reviewFerruccio Romano, Maria K Haanpää, Pawel Pomianowski, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Epilepsy Currents|September 18, 2020
The Impact of COVID-19 on Epilepsy Care: A Survey of the American Epilepsy Society MembershipDara V F Albert, Rohit R Das, Jayant N Acharya, et al.
Epilepsia|March 2, 2013
Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trialsDale C Hesdorffer, Jacqueline A French, Kelly Posner, et al.
Epilepsia|July 4, 2019
Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participantsJacqueline A French, Robert Wechsler, Michael A Gelfand, et al.
Acta Crystallographica. Section D, Biological Crystallography|May 13, 2014
Structure of human Bloom's syndrome helicase in complex with ADP and duplex DNAMichael K Swan, Valerie Legris, Adam Tanner, et al.
Frontiers in Neurology|January 8, 2013
The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant EpilepsyJohn R Pollard, Ofer Eidelman, Gregory P Mueller, et al.
ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties|September 30, 2015
Lateral Transorbital Endoscopic Access to the Hippocampus, Amygdala, and Entorhinal Cortex: Initial Clinical ExperienceH Isaac Chen, Leif-Erik Bohman, Lyndsey Emery, et al.
Cancer Research|October 2, 2014
ATR inhibitors VE-821 and VX-970 sensitize cancer cells to topoisomerase i inhibitors by disabling DNA replication initiation and fork elongation responsesRozenn Jossé, Scott E Martin, Rajarshi Guha, et al.
The Lancet. Neurology|February 16, 2016
Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trialMichael D Privitera, Timothy E Welty, Barry E Gidal, et al.
Oncotarget|October 22, 2015
Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibitionFiona K Middleton, Miranda J Patterson, Claire J Elstob, et al.
American Journal of Medical Genetics. Part A|February 6, 2024
Expanding the phenotype of UPF3B-related disorder: Case reports and literature reviewFerruccio Romano, Maria K Haanpää, Pawel Pomianowski, et al.
Pageof 4